Millions spent on lobbyists by companies who can benefit from new anti-opiate bills in Congress
Opioid bills could net millions for companies ‘For years, we got the scraps. And now we’re the big time,’ says an anti-addiction consultant. The House is touting passage of dozens of bills that cou…
